Andrea R Horvath
Andrea R Horvath
Increasing patient risks and costs associated with the delivery of health care services have been related to inappropriate and uncontrolled use of biomarkers which make evidence-based guideline recommendations for best practice increasingly...
Jayesh Warade
Jayesh Warade
Point-of-care testing (POCT) has evolved as an important part of laboratory medicine by virtue of its compactness, portability, and the feasibility of operation by nonlaboratory personnel, where fast and accurate testing methods are a prima...
Clinical Relevance of Trace Bands on Serum Electrophoresis in Patients Without a History of Gammopathy [0.03%]
无单克隆免疫球蛋白病史患者的血清电泳中的区带的临床意义
TanYa M Gwathmey,Monte S Willis,Jason Tatreau et al.
TanYa M Gwathmey et al.
Serum protein electrophoresis (SPE) and immunofixation is commonly used to screen for plasma cell dyscrasias. Interpretation of these tests is qualitative by nature and can yield trace, faint, or scarcely visible immunoglobulin bands (TFS),...
Yonah Krakowsky,Ethan D Grober
Yonah Krakowsky
Testosterone deficiency is a common and often unrecognized disorder impacting the lives of many men. Symptoms related to low testosterone are relatively non-specific and clinicians must therefore ensure that a patients' symptomatology is su...
Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer [0.03%]
代谢组学及其在开发前列腺癌临床检验项目中的应用
Jonathan E McDunn,Steven M Stirdivant,Lisa A Ford et al.
Jonathan E McDunn et al.
Introduction: There is a critical need to develop clinical laboratory assays that provide risk assessment for men at elevated risk for prostate cancer, and once diagnosed, could further identify those men with clinically ...
Christopher J D Wallis,Robert K Nam
Christopher J D Wallis
Over the past decades, research has focussed on identifying the genetic underpinnings of prostate cancer. It has been recognized that a number of forms of genetic changes coupled with epigenetic and gene expression changes can increase the ...
Patrick M Bossuyt,Tajik Parvin
Patrick M Bossuyt
The genetic revolution is expected to lead to improved targeting of new and existing forms of treatment. Rather than a one-size-fits-all blockbuster strategy in battling disease with drugs and other interventions, a more precise approach is...
The Clinical and Health Economic Value of Clinical Laboratory Diagnostics [0.03%]
临床实验室诊断的临床和卫生经济学价值
Bruce Jordan,Cheryl Mitchell,Andy Anderson et al.
Bruce Jordan et al.
The ultimate goal of diagnostic testing is to guide disease management in order to improve patient outcomes and patient well-being. Patient populations are rarely homogenous and accurate diagnostic tests can dissect the patient population a...
The Impact for Patient Outcomes of Failure to Follow Up on Test Results. How Can We Do Better? [0.03%]
检查结果未随访对患者预后的影响及改进建议
Joanne Callen,Andrew Georgiou,Julie Li et al.
Joanne Callen et al.
Background: The World Health Organization-World Alliance for Patient Safety has identified test result management as a priority area. Poor test result follow-up can have major consequences for the quality of care, includi...
Howard A Morris
Howard A Morris
The provision of quality laboratory services for patient care to improve healthcare outcomes is at the centre of the work of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). However the day to day work of l...